Published in Rofo on August 01, 1977
Plasma 4beta-hydroxycholesterol: an endogenous CYP3A metric? Clin Pharmacol Ther (2009) 1.66
Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics J (2005) 1.53
Study of values test and collegiate football teams. Res Q (1965) 1.42
Development of a new G-CSF product based on biosimilarity assessment. Ann Oncol (2009) 1.41
Pharmacokinetics and pharmacodynamics of moist inhalation epinephrine using a mobile inhaler. Eur J Clin Pharmacol (2013) 1.35
Pharmacokinetics of inhaled anaesthetics in a clinical setting: comparison of desflurane, isoflurane and sevoflurane. Br J Anaesth (2000) 1.33
Reliability theory and research decision in selection of a criterion score. Res Q (1967) 1.32
Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantation. Antimicrob Agents Chemother (2009) 1.24
Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients. Clin Pharmacol Ther (2008) 1.23
Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics (1999) 1.23
The clinical role of genetic polymorphisms in drug-metabolizing enzymes. Pharmacogenomics J (2007) 1.21
Pharmacokinetics of inhaled anaesthetics in a clinical setting: description of a novel method based on routine monitoring data. Br J Anaesth (2000) 1.20
Dosing accuracy of commonly used disposable insulin pens. Curr Med Res Opin (2010) 1.20
Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping. Eur J Clin Pharmacol (2007) 1.14
Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule. Br J Clin Pharmacol (1990) 1.08
Pharmacokinetic/pharmacodynamic modeling of biomarker response to sunitinib in healthy volunteers. Clin Pharmacol Ther (2010) 1.06
Accelerated bone maturation syndrome of the Weaver type. Eur J Pediatr (1981) 0.99
Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid. Int J Clin Pharmacol Ther Toxicol (1989) 0.97
Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeine. Clin Pharmacokinet (1992) 0.93
Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmacokinetics of dextromethorphan. Clin Pharmacol Ther (2010) 0.92
Pharmacokinetics of ibuprofen sodium dihydrate and gastrointestinal tolerability of short-term treatment with a novel, rapidly absorbed formulation. Int J Clin Pharmacol Ther (2005) 0.92
Effect of pretreatment with the selective beta 1-adrenoceptor antagonist bisoprolol on the subsequent cardiovascular actions and beta-adrenoceptor subtype specific occupancy of celiprolol in healthy man. Eur J Clin Pharmacol (1993) 0.91
Dermal absorption of permethrin following topical administration. Eur J Clin Pharmacol (2005) 0.90
Slipped epiphyses in renal osteodystrophy. Arch Dis Child (1975) 0.90
Discriminant function and hierarchial grouping analysis of karate participants' personality profiles. Res Q (1967) 0.89
Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes. Pharmacol Toxicol (2000) 0.89
Problems and perspectives of phenotyping for drug-metabolizing enzymes in man. Int J Clin Pharmacol Ther (2000) 0.89
Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers. Eur J Clin Pharmacol (2011) 0.89
Cystinosis: quantitative assay of cystine accumulation of homozygotes and heterozygotes. Humangenetik (1973) 0.88
Radiological kidney size in childhood. Pediatr Radiol (1980) 0.88
Effect of propiverine on cytochrome P450 enzymes: a cocktail interaction study in healthy volunteers. Drug Metab Dispos (2005) 0.87
Age, isometric knee extension strength, and fractionated resisted response time. Exp Aging Res (1978) 0.87
Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes. Int J Clin Pharmacol Ther (2001) 0.87
Nephrocalcinosis in radiographs, computed tomography, sonography and histology. Pediatr Radiol (1980) 0.85
Regional adipose cellularity and reliability of adipose cell size determination. Am J Clin Nutr (1980) 0.85
Comparison of enzyme kinetic parameters obtained in vitro for reactions mediated by human CYP2C enzymes including major CYP2C9 variants. Curr Drug Metab (2010) 0.85
Verapamil and drug metabolism by the cytochrome P450 isoform CYP1A2. Eur J Clin Pharmacol (1992) 0.85
Absence of prognostic significance of skeletal involvement in acute lymphocytic leukemia and non-Hodgkin lymphoma in children. Pediatr Radiol (1985) 0.84
Roentgenological signs in the skeleton of uremic children. An analysis of the anatomical principles underlying the roentgenological changes. Pediatr Radiol (1973) 0.84
Condensing osteitis of the clavicle in childhood: a rare sclerotic bone lesion. Review of literature and report of seven patients. Pediatr Radiol (1983) 0.84
Age, isometric strength, rate of tension development and fiber type composition. J Gerontol (1981) 0.84
Cystinosis: a review of the different forms and of recent advances. Humangenetik (1973) 0.84
Plasma and tissue pharmacokinetics of epirubicin and Paclitaxel in patients receiving neoadjuvant chemotherapy for locally advanced primary breast cancer. Clin Pharmacol Ther (2007) 0.83
[Intracranial calcifications in childhood]. Fortschr Geb Rontgenstr Nuklearmed (1972) 0.83
Variation of CYP1A2-dependent caffeine metabolism during menstrual cycle in healthy women. Int J Clin Pharmacol Ther (2000) 0.82
Enzyme immunoassay for the measurement of human tenascin-C on the Bayer Immuno 1 analyzer. Clin Biochem (2000) 0.81
Investigation of nifedipine absorption in different regions of the human gastrointestinal (GI) tract after simultaneous administration of 13C- and 12C-nifedipine. Eur J Clin Pharmacol (1996) 0.81
The relationship of serum creatine kinase, fiber type, and isometric exercise. Int J Sports Med (1982) 0.81
Isokinetic strength, endurance, and fiber type composition in elite American paddlers. Eur J Appl Physiol Occup Physiol (1982) 0.81
[Contribution to pterygoarthromyodysplasia congenita (Rossi syndrome) (author's transl)]. Z Kinderheilkd (1974) 0.80
Drug metabolism biosensors: electrochemical reactivities of cytochrome P450cam immobilised in synthetic vesicular systems. J Pharm Biomed Anal (1998) 0.80
Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2. Clin Pharmacol Ther (1999) 0.80
Skeletal fingings in homocystinuria: a collaborative study. Pediatr Radiol (1973) 0.80
Maximal isometric strength and fiber type composition in power and endurance athletes. Eur J Appl Physiol Occup Physiol (1980) 0.79
The role of active metabolites in dihydrocodeine effects. Int J Clin Pharmacol Ther (2003) 0.79
Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome. Eur J Clin Pharmacol (2012) 0.79
Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations. Am J Med (1989) 0.78
Liver cytochrome P450 CYP1A2 is markedly inhibited by systemic but not by bath PUVA in dermatological patients. Br J Dermatol (2001) 0.78
Absorption behavior of sulpiride described using Weibull functions. Int J Clin Pharmacol Ther (1995) 0.78
No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam. Eur J Clin Pharmacol (2008) 0.78
Energy parameters, macromolecular synthesis and cell cycle progression of in vitro grown Ehrlich ascites tumor cells after inhibition of oxidative ATP synthesis by oligomycin. Z Naturforsch C (1983) 0.78
Epitope-specific monoclonal antibodies against human C-terminal procollagen alpha1(III)-propeptide. Matrix Biol (1998) 0.77
Uroporphyrinogen oxidation catalyzed by human cytochromes P450. Drug Metab Dispos (1998) 0.77
Spinal growth after irradiation for Wilm's tumour. Int Orthop (1991) 0.77
Segmental renal hypoplasia in childhood. Pediatr Radiol (1976) 0.77
The role of Gilbert's syndrome and frequent NAT2 slow acetylation polymorphisms in the pharmacokinetics of retigabine. Pharmacogenomics J (2006) 0.76
Test reliability and errors of measurement at several levels of absolute isometric strength. Res Q (1970) 0.76
Isometric strength and endurance under successive induction conditions. Am Correct Ther J (1972) 0.76
Population pharmacokinetics of cyclophosphamide, doxorubicin and etoposide in 30 patients with BEACOPP chemotherapy. Int J Clin Pharmacol Ther (2002) 0.76
Practice effects on fractionated response time related to age and activity level. J Mot Behav (1978) 0.76
[Syndrome of caudal hypoplasia with additional malformations in unbalanced translocation 13-15-16]. Z Kinderheilkd (1969) 0.76
An EMG-level muscle model for a fast arm movement to target. Biol Cybern (1982) 0.76
Patellar reflex time and reflex latency under Jendrassik and crossed extensor facilitation. Am J Phys Med (1968) 0.76
The 1981 C. H. McCloy Research Lecture. Analysis of local muscular fatigue patterns. Res Q Exerc Sport (1981) 0.76
Suprapubic micturition cystourethrography in infancy and childhood. Pediatr Radiol (1975) 0.75
Knee and ankle extension isometric endurance and muscle composition in power and endurance athletes. J Sports Med Phys Fitness (1980) 0.75
Absence of effect of rufloxacin on theophylline pharmacokinetics in steady state. Antimicrob Agents Chemother (1998) 0.75
Inhibitory effects of trospium chloride on cytochrome P450 enzymes in human liver microsomes. Pharmacol Toxicol (1999) 0.75
Omeprazole weakly inhibits CYP1A2 activity in man. Int J Clin Pharmacol Ther (1999) 0.75
[Invasion of the growth plate by bone tumors and osteomyelitis in childhood]. Radiologe (1995) 0.75
Theophylline metabolism affected by mexiletine. Clin Pharmacol Ther (1992) 0.75
[Comment) on the position paper, "Procedures for completion of a subspecialization"]. Z Erkr Atmungsorgane (1990) 0.75
On the stability of delay equation models of simple human stretch reflexes. J Math Biol (1983) 0.75
Post vibratory effects on fractionated patellar and Achilles reflex times. Am Correct Ther J (1982) 0.75
Proliferation kinetics and metabolic features of in vitro grown Ehrlich ascites tumor cells in the presence of exogenous pyruvate. Z Naturforsch C (1986) 0.75
A constant chromosome aberration in two children with acute myeloic leukaemia. Humangenetik (1967) 0.75
[The metacarpal sign (author's transl)]. Fortschr Geb Rontgenstr Nuklearmed (1973) 0.75
[Gonadal dysgenesis (XO-XY) in a girl aged 14 years: chromosomal, histological, and endocrinological studies]. Monatsschr Kinderheilkd (1972) 0.75
Modification of the BrdU/H33258 technique for flow cytometry based on the pH-dependence of the fluorescence of H33258 stained DNA. Histochemistry (1984) 0.75
A comparison of four methods to measure fat cell size. Am J Clin Nutr (1981) 0.75
Recovery patterns after local muscular fatigue for different levels of isometric strength. Int Z Angew Physiol (1967) 0.75
Isometric knee extension and plantar flexion muscle fatigue and fiber type composition in female distance runners. Res Q Exerc Sport (1981) 0.75
Literature in pediatric radiology. Pediatr Radiol (1973) 0.75
Isometric bilateral reciprocal exercise. Arch Phys Med Rehabil (1972) 0.75
Cell cycle kinetics and metabolism of Ehrlich ascites tumor cells in the presence of chloramphenicol as inhibitor of mitochondrial protein synthesis. Z Naturforsch C (1984) 0.75
Growth kinetics of the G2-phase of Ehrlich ascites tumor cells, separated from anaerobically treated asynchronous cultures. Z Naturforsch C (1988) 0.75
A flow cytometric assay for the determination of cell proliferation with a monoclonal antibody directed against DNA-methyltransferase. Br J Haematol (1989) 0.75
A further attempt to cross-validate the Booth Scale of competitive behavior. J Assoc Phys Ment Rehabil (1966) 0.75
Achalasia of the cardia in children. Manometric, cinematographic and pharmacoradiographic studies. Pediatr Radiol (1973) 0.75
Recent progress in our knowledge of cystinosis. Clin Endocrinol Metab (1974) 0.75